Brent Pfeiffenberger, President and CEO at Century Therapeutics, Inc. (IPSC), sold 475 shares at $0.62 ($295) on 2025-06-09, disclosed to the SEC on 2025-06-11.
Open-market sale of $294 IPSC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IPSC | SELL | 2025-11-19 | $15K | — | Filing → |
| IPSC | SELL | 2025-09-10 | $244 | — | Filing → |
| IPSC | SELL | 2025-05-20 | $16K | — | Filing → |